International "Comparability" Of Regulatory Standards May Be FDA's Solution To GMP Oversight
This article was originally published in PharmAsia News
Executive Summary
FDA may begin to rely on foreign government oversight of manufacturing even if the standards for the overseas regulators do not exactly match those in the U.S